Skip to main content
. 2020 Apr 7;10:380. doi: 10.3389/fonc.2020.00380

Figure 1.

Figure 1

Disease-related indicators before and after neoadjuvant chemotherapy for colorectal cancer. (A) Hematoxylin-eosin (HE) staining showing the tumor-stroma ratio before and after neoadjuvant chemotherapy. Immunohistochemical staining of GALC (B), Ki67 (C), p53 (D), and E-cadherin (E) was performed to explore the relationship between these markers and prognosis. p < 0.05 was considered statistically significant.